Cantitate/Preț
Produs
Total produse
Vezi coșul
Asbestos and Mesothelioma de Joseph R. Testa

Asbestos and Mesothelioma: Current Cancer Research

Editat de Joseph R. Testa
en Limba Engleză Hardback – 18 apr 2017
This volume is comprised of a multidisciplinary assessment of the interplay between asbestos and cancer as well as new research about the biology and treatment of malignant mesothelioma.  Chapters on the various types of asbestos and other mineral fibers, epidemiology, history and future of asbestos-related diseases are included.  Other reviews present new information about the role of asbestos-related inflammation and genetic factors, including the role of inherited mutations of BAP1, in mesothelioma causation, as well as recent research about gene signatures, cell signaling, and epigenetic mechanisms in asbestos-related diseases.  Other chapters provide updates of novel disease biomarkers and prevention, mechanistic lesson from genetically engineered mouse and 3-D models of mesothelioma tumorigenesis and therapeutic resistance.  Also included are up-to-date reviews of surgical, molecularly targeted chemotherapeutic, and immunotherapeutic approaches for mesothelioma as well as an overview of legal issues.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 89623 lei  6-8 săpt.
  Springer International Publishing – 8 aug 2018 89623 lei  6-8 săpt.
Hardback (1) 127532 lei  6-8 săpt.
  Springer International Publishing – 18 apr 2017 127532 lei  6-8 săpt.

Din seria Current Cancer Research

  • 5% Targeted Therapy of Acute Myeloid Leukemia
    Preț: 111298 lei
  • 5% Molecular Determinants of Head and Neck Cancer
    Preț: 158235 lei
  • 5% Lung Cancer: New Understandings and Therapies
    Preț: 72866 lei
  • 5% Protein Kinase C in Cancer Signaling and Therapy
    Preț: 139721 lei
  • 5% Gene-Based Therapies for Cancer
    Preț: 107562 lei
  • 5% Cell Cycle Deregulation in Cancer
    Preț: 107146 lei
  • 5% Chemical Carcinogenesis
    Preț: 145654 lei
  • 5% Molecular Determinants of Radiation Response
    Preț: 107634 lei
  • 5% Cancer Associated Viruses
    Preț: 142330 lei
  • 5% Caveolins in Cancer Pathogenesis, Prevention and Therapy
    Preț: 69506 lei
  • 5% Burkitt’s Lymphoma
    Preț: 107832 lei
  • 5% Autophagy and Cancer
    Preț: 107995 lei
  • 5% Advances in Tumor Immunology and Immunotherapy
    Preț: 109342 lei
  • 5% Targeting Autophagy in Cancer Therapy
    Preț: 70260 lei
  • 5% Advances in Biology and Treatment of Glioblastoma
    Preț: 108208 lei
  • 5% Early Phase Cancer Immunotherapy
    Preț: 108533 lei
  • 5% D-type Cyclins and Cancer
    Preț: 70332 lei
  • 5% Microbiome and Cancer
    Preț: 115126 lei
  • 5% Targeted Therapies for Lung Cancer
    Preț: 88722 lei
  • 5% Engineering and Physical Approaches to Cancer
    Preț: 158129 lei
  • 5% Circulating Tumor Cells: Advances in Liquid Biopsy Technologies
    Preț: 141450 lei

Preț: 127532 lei

Preț vechi: 134245 lei
-5% Nou

Puncte Express: 1913
Preț estimativ în valută:
24418€ • 25427$ • 20260£

Carte tipărită la comandă

Livrare economică 13-27 februarie

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783319535586
ISBN-10: 3319535587
Pagini: 490
Ilustrații: VIII, 407 p. 65 illus., 43 illus. in color.
Dimensiuni: 155 x 235 x 24 mm
Greutate: 0.76 kg
Ediția:1st ed. 2017
Editura: Springer International Publishing
Colecția Springer
Seria Current Cancer Research

Locul publicării:Cham, Switzerland

Cuprins

1. Malignant Mesothelioma – An Asbestos Legacy.- 2. Asbestos and Fibrous Erionite.- 3. Epidemiology of Mesothelioma.- 4. Malignant Pleural Mesothelioma: History, Controversy and Future of a Man-Made Epidemic .- 5. Communities at High Risk in the Third Wave of Mesothelioma.- 6. Mesothelioma Pathology.- 7. Asbestos-Induced Inflammation in Malignant Mesothelioma and Other Lung Diseases.- 8. Germline and Somatic Mutations in Human Mesothelioma and Lessons from Asbestos-Exposed Genetically Engineered Mouse Models.- 9. Gene Signature of Malignant Pleural Mesothelioma.- 10. Cell Signaling and Epigenetic Mechanisms in Mesothelioma.- 11. 3D Models of Mesothelioma in the Study of Mechanisms of Cell Survival.- 12. Biomarkers of Response to Asbestos Exposure.- 13. Surgery Approaches in Mesothelioma.- 14. Radiotherapy and Photodynamic Therapy for Malignant Pleural Mesothelioma.- 15. Standard Chemotherapy Options and Clinical Trials of Novel Agents for Mesothelioma.- 16. Immunotherapeutic Approachesto Mesothelioma.- 17. Challenges Facing Mesothelioma Patients and Their Families: Medical/Legal Intersections.- 18. The Patient’s Experience of Malignant Mesothelioma.

Notă biografică

Joseph R. Testa, PhD, FACMG is Senior Member/Professor, Carol and Kenneth E. Weg Chair in Human Genetics, Chief of Laboratory Genetics, and Co-Leader of the Cancer Biology Program at Fox Chase Cancer Center, Philadelphia, PA. His research interests focus on mesothelioma pathogenesis and AKT-related oncogenesis. He has published numerous papers and reviews, and serves on the editorial boards of several journals, including as Senior Editor for Cancer Research. He has received multiple science awards, including the J. Christopher Wagner Medal from the International Mesothelioma Interest Group and the Pioneer Research Award from the Mesothelioma Applied Research Foundation. He is also a Fellow of the American Association for the Advancement of Science.

Textul de pe ultima copertă

This volume is comprised of a multidisciplinary assessment of the interplay between asbestos and cancer as well as new research about the biology and treatment of malignant mesothelioma.  Chapters on the various types of asbestos and other mineral fibers, epidemiology, history and future of asbestos-related diseases are included.  Other reviews present new information about the role of asbestos-related inflammation and genetic factors, including the role of inherited mutations of BAP1, in mesothelioma causation, as well as recent research about gene signatures, cell signaling, and epigenetic mechanisms in asbestos-related diseases.  Other chapters provide updates of novel disease biomarkers and prevention, mechanistic lesson from genetically engineered mouse and 3-D models of mesothelioma tumorigenesis and therapeutic resistance.  Also included are up-to-date reviews of surgical, molecularly targeted chemotherapeutic, and immunotherapeutic approaches for mesothelioma as well as an overview of legal issues.

Caracteristici

Disseminates for the first time information from a study demonstrating that inherited mutations can influence a person’s risk of mesothelioma Addresses the fact that, besides mesothelioma, some of the BAP1 mutation carriers developed ocular melanoma or other cancers, and this cancer susceptibility is now recognized as the BAP1 Syndrome Highlights will be the various molecular signaling pathways that are hyper-activated in this disease, facilitating the identification of novel druggable targets for cancer therapy or prevention Includes supplementary material: sn.pub/extras